Eleftheria Hatzimichael, MD, PhD is Associate Professor of Haematology at the Faculty of Medicine, School of Health Sciences, University of Ioannina, Greece. She is a board-certified haematologist with extensive clinical, academic and research experience in haematological malignancies.
She trained in Haematology at St Bartholomew’s Hospital, Barts and The London, UK, and at the University Hospital of Ioannina. She subsequently received a competitive fellowship from the Hellenic Society of Hematology Foundation to undertake research at the Computational Medicine Center, Thomas Jefferson University, USA, focusing on the non-coding genome through computational and experimental approaches.
Her research interests include myelodysplastic neoplasms, haematological malignancies, epigenetics, non-coding RNAs, molecular biomarkers, precision medicine and translational research. She has extensive experience in clinical research and has served as Principal Investigator in more than 50 Phase I–IV clinical trials across a broad spectrum of haematological malignancies.
She has authored or co-authored more than 150 peer-reviewed publications and maintains an active international research network. Her academic activities encompass medical education, scientific publishing and leadership within national and European haematology organisations.
More recently, her work has expanded to the responsible integration of artificial intelligence in medicine, clinical research and medical education, with particular emphasis on maintaining human-centred clinical practice while harnessing emerging technologies.
Research interests: Haematological malignancies · Myelodysplastic neoplasms · Clinical trials · Translational research · Epigenetics · Non-coding RNAs · Molecular biomarkers · Precision medicine · Responsible AI in Medicine
She trained in Haematology at St Bartholomew’s Hospital, Barts and The London, UK, and at the University Hospital of Ioannina. She subsequently received a competitive fellowship from the Hellenic Society of Hematology Foundation to undertake research at the Computational Medicine Center, Thomas Jefferson University, USA, focusing on the non-coding genome through computational and experimental approaches.
Her research interests include myelodysplastic neoplasms, haematological malignancies, epigenetics, non-coding RNAs, molecular biomarkers, precision medicine and translational research. She has extensive experience in clinical research and has served as Principal Investigator in more than 50 Phase I–IV clinical trials across a broad spectrum of haematological malignancies.
She has authored or co-authored more than 150 peer-reviewed publications and maintains an active international research network. Her academic activities encompass medical education, scientific publishing and leadership within national and European haematology organisations.
More recently, her work has expanded to the responsible integration of artificial intelligence in medicine, clinical research and medical education, with particular emphasis on maintaining human-centred clinical practice while harnessing emerging technologies.
Research interests: Haematological malignancies · Myelodysplastic neoplasms · Clinical trials · Translational research · Epigenetics · Non-coding RNAs · Molecular biomarkers · Precision medicine · Responsible AI in Medicine
